BEN
71
2
LUV
71
4
YUM
59
2
KSS
65
-4
AON
52
-6
MAT
68
-5
HAS
68
-5
RRC
56
4
AN
57
3
A
53
2
ORLY
52
4
SWK
70
2
ILMN
68
-3
CL
45
2
MCK
66
2
HIG
62
-4
MTB
69
-2
DHR
70
2
LB
29
11
DUK
55
-2
BEN
71
2
LUV
71
4
YUM
59
2
KSS
65
-4
AON
52
-6
MAT
68
-5
HAS
68
-5
RRC
56
4
AN
57
3
A
53
2
ORLY
52
4
SWK
70
2
ILMN
68
-3
CL
45
2
MCK
66
2
HIG
62
-4
MTB
69
-2
DHR
70
2
LB
29
11
DUK
55
-2
Financhill
Back

ADMA Biologics, Inc. Stock Predictions

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
57

ADMA
ADMA Biologics, Inc.

Last Price:
$17.93
Seasonality Move:
11.5%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

ADMA Biologics, Inc. Stock Forecast

  • Over the next 52 weeks, ADMA Biologics, Inc. has on average historically risen by 30.7% based on the past 12 years of stock performance.
  • ADMA Biologics, Inc. has risen higher in 6 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is ADMA Biologics, Inc. Stock Undervalued?
    The current ADMA Biologics, Inc. [ADMA] share price is $17.95. The Score for ADMA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • ADMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ADMA Biologics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, ADMA Biologics, Inc. has on average historically risen by 30.7% based on the past 12 years of stock performance.

ADMA Biologics, Inc. Stock Rating

Buy
57
ADMA Biologics, Inc. (ADMA) is a Buy

Is ADMA Biologics, Inc. overpriced?

  • ADMA Biologics, Inc. has risen higher in 6 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

ADMA Biologics, Inc. Stock Price History

Is ADMA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
admabiologics.com

52-Week Data

52-Week High:
25.67
52-Week Low:
13.50

Prediction Charts

Market Cap:
4.3B
Price in USD:
17.95
Volume:
2.2M
Beta:
1.07

Technical Analysis

SMA50:
17.79
SMA100:
16.78
SMA200:
18.16
52-Wk Change:
-3.29%

Stock Predictions

  • Is ADMA Biologics, Inc. stock public?
    Yes, ADMA Biologics, Inc. is a publicly traded company.
  • What is the ADMA Biologics, Inc. stock quote today?
    The ADMA Biologics, Inc. stock price is 17.95 USD today.
  • How to buy ADMA Biologics, Inc. stock online?
    You can buy ADMA Biologics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 18.85 18.81 19.24 18.75
Dec-19 18.80 19.58 19.69 18.80
Dec-22 19.58 19.88 19.94 19.53
Dec-23 19.84 19.49 19.84 19.49
Dec-24 19.57 19.54 19.69 19.36
Dec-26 19.53 19.28 19.53 19.23
Dec-29 19.21 19.11 19.40 19.00
Dec-30 19.07 18.36 19.19 18.32
Dec-31 18.32 18.24 18.40 18.17
Jan-5 17.89 18.03 18.19 17.65
Jan-6 18.08 18.34 18.55 17.88
Jan-7 18.48 18.82 18.95 18.21
Jan-8 18.57 18.07 18.76 17.92
Jan-9 18.06 17.95 18.19 17.86

ADMA Biologics, Inc. Earnings

ADMA Biologics, Inc. Earnings Report: Per Share ADMA Biologics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

ADMA Biologics, Inc. Forecast Revenue Growth

ADMA Biologics, Inc. Stock Analysis: Historical quarterly revenues per share for ADMA Biologics, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.24 per share.

* ADMA Biologics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.